FOAM Biotechnology Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
FOAM Biotechnology General Information
Description
Manufacturer of comprehensive public restrooms intended for public sanitation and water conservation. The company utilizes foam-based flushing, automated cleaning robotics, aerosol blocking, Internet of Things monitoring, and organic wastewater resource recovery, enabling municipal and commercial clients to maintain hygiene standards and reduce operational costs.
Contact Information
Website
www.jsfmhb.comCorporate Office
- Yangtze River Biomedical Accelerator A8-2
- Number 6 Dongsheng West Road, Jiangyin
- Jiangyin, Jiangsu 214400
- China
Corporate Office
- Yangtze River Biomedical Accelerator A8-2
- Number 6 Dongsheng West Road, Jiangyin
- Jiangyin, Jiangsu 214400
- China
FOAM Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 25-Aug-2026 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 03-Sep-2024 | Completed | Generating Revenue |
FOAM Biotechnology Signals
FOAM Biotechnology Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jiangsu New Supply and Marketing Fund Management | Growth/Expansion | Minority |
FOAM Biotechnology FAQs
-
When was FOAM Biotechnology founded?
FOAM Biotechnology was founded in 2014.
-
Where is FOAM Biotechnology headquartered?
FOAM Biotechnology is headquartered in Jiangyin, China.
-
What is the size of FOAM Biotechnology?
FOAM Biotechnology has 120 total employees.
-
What industry is FOAM Biotechnology in?
FOAM Biotechnology’s primary industry is Building Products.
-
Is FOAM Biotechnology a private or public company?
FOAM Biotechnology is a Private company.
-
What is FOAM Biotechnology’s current revenue?
The current revenue for FOAM Biotechnology is .
-
Who are FOAM Biotechnology’s investors?
Jiangsu New Supply and Marketing Fund Management has invested in FOAM Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process